ALPRAZolam 3 mg 24HR Extended Release Oral Tablet
RxNorm 433801
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 433801 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ALPRAZolam 3 mg 24HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR alprazolam 3 mg Extended Release Oral Tablet
(Atom ID: 12347673)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
24 HR ALPRAZolam 3 mg Extended Release Oral Tablet
(Atom ID: 6378437)
SYPrescribable
Synonym (SY):
Alprazolam 3 mg 24 HR Extended Release Oral Tablet
(Atom ID: 6354558)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ALPRAZolam 3 mg 24 HR Extended Release Oral Tablet
(Atom ID: 6375552)
PSNPrescribable
Prescribable Name (PSN):
ALPRAZolam 3 mg 24HR Extended Release Oral Tablet
(Atom ID: 6363772)
PTPrescribable
Designated preferred name (PT):
Alprazolam 3 mg prolonged-release oral tablet
(Atom ID: 12900789)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely alprazolam 3 mg/1 each prolonged-release oral tablet (clinical drug)
(Atom ID: 12903655)
Patient Education
Alprazolam
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.